Cargando…

Targeting of Lysosomal Pathway Genes for Parkinson's Disease Modification: Insights From Cellular and Animal Models

Previous genetic studies on hereditary Parkinson's disease (PD) have identified a set of pathogenic gene mutations that have strong impacts on the pathogenicity of PD. In addition, genome-wide association studies (GWAS) targeted to sporadic PD have nominated an increasing number of genetic vari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abe, Tetsuro, Kuwahara, Tomoki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236816/ https://www.ncbi.nlm.nih.gov/pubmed/34194386 http://dx.doi.org/10.3389/fneur.2021.681369

Ejemplares similares

Selecting the Best Animal Model of Parkinson’s Disease for Your Research Purpose: Insight from in vivo PET Imaging Studies
por: Real, Caroline Cristiano, et al.
Publicado: (2023)

Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis
por: Xu, Xuxu, et al.
Publicado: (2023)

Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease
por: Palasz, Ewelina, et al.
Publicado: (2019)

Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson´s Disease
por: Rivero-Ríos, Pilar, et al.
Publicado: (2016)

Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?
por: Fuzzati-Armentero, Marie Therese, et al.
Publicado: (2019)

Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2021)

Identification of Disease-Associated Variants by Targeted Gene Panel Resequencing in Parkinson's Disease
por: Daida, Kensuke, et al.
Publicado: (2020)

Investigation of Somatic Mutations in Human Brains Targeting Genes Associated With Parkinson's Disease
por: Leija-Salazar, Melissa, et al.
Publicado: (2020)

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models
por: Spathopoulou, Angeliki, et al.
Publicado: (2022)

Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease
por: Costas, Carmen, et al.
Publicado: (2022)

The Gut and Parkinson's Disease—A Bidirectional Pathway
por: Santos, Susanne Fonseca, et al.
Publicado: (2019)

The Gut Dysmotility Questionnaire for Parkinson's disease: Insights into development and pretest studies
por: Raeder, Vanessa, et al.
Publicado: (2023)

Disease modification in Parkinsonism: obstacles and ways forward
por: Höllerhage, M., et al.
Publicado: (2022)

Identification of key genes and signaling pathways associated with dementia with Lewy bodies and Parkinson's disease dementia using bioinformatics
por: Xu, Jing, et al.
Publicado: (2023)

Insights into the Cellular Interactions and Molecular Mechanisms of Ketogenic Diet for Comprehensive Management of Epilepsy
por: Kumar, Amit, et al.
Publicado: (2022)

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
por: Menon, Sindhu, et al.
Publicado: (2022)

Sub-cellular sequestration of alkaline drugs in lysosomes: new insights for pharmaceutical development of lysosomal fluid
por: Yousef, Malaz, et al.
Publicado: (2022)

Association Between a Variable Number Tandem Repeat Polymorphism Within the DAT1 Gene and the Mesolimbic Pathway in Parkinson's Disease
por: du Plessis, Stefan, et al.
Publicado: (2020)

Modification of Acute Stroke Pathway in Korea After the Coronavirus Disease 2019 Outbreak
por: Kim, Tae Jung, et al.
Publicado: (2020)

Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease
por: Barilar, Jelena Osmanovic, et al.
Publicado: (2020)

Editorial: Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2022)

LRRK2 and RAB7L1 coordinately regulate axonal morphology and lysosome integrity in diverse cellular contexts
por: Kuwahara, Tomoki, et al.
Publicado: (2016)

Azathioprine immunosuppression and disease modification in Parkinson’s disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol
por: Greenland, Julia C, et al.
Publicado: (2020)

Extended Study of NUS1 Gene Variants in Parkinson's Disease
por: Yuan, Lamei, et al.
Publicado: (2020)

Editorial: Neuroimaging in Parkinson's disease and Parkinsonism
por: Zhang, Yu, et al.
Publicado: (2023)

N-Acetylcysteine Reverses Antiretroviral-Mediated Microglial Activation by Attenuating Autophagy-Lysosomal Dysfunction
por: Tripathi, Ashutosh, et al.
Publicado: (2020)

Animal Models for Neuroinflammation and Potential Treatment Methods
por: Tamura, Yasuhisa, et al.
Publicado: (2022)

Editorial: Peripheral Immunity in Parkinson's Disease: Emerging Role and Novel Target for Therapeutics
por: Comi, Cristoforo, et al.
Publicado: (2019)

Neuropathological features of levodopa-responsive parkinsonism in multiple system atrophy: an autopsy case report and comparative neuropathological study
por: Tamura, Mitsuyoshi, et al.
Publicado: (2023)

A Modification to a Murine Model for Intracranial Aneurysm Formation and Rupture
por: Patel, Devan, et al.
Publicado: (2021)

Towards early disease modification of Parkinson’s disease: a review of lessons learned in the Alzheimer field
por: Smedinga, Marthe, et al.
Publicado: (2020)

A historical review of multiple system atrophy with a critical appraisal of cellular and animal models
por: Marmion, David J., et al.
Publicado: (2021)

Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models
por: Volta, Mattia
Publicado: (2022)

Cortical excitability in patients with REM sleep behavior disorder with abnormal TRODAT-1 SPECT scan: an insight into prodromal Parkinson’s disease
por: Su, Siao-Chu, et al.
Publicado: (2023)

Identifying a Comprehensive ceRNA Network to Reveal Novel Targets for the Pathogenesis of Parkinson's Disease
por: Zhang, Xi, et al.
Publicado: (2020)

Lipid-lowering drug targets and Parkinson's disease: A sex-specific Mendelian randomization study
por: Zhao, Yangfan, et al.
Publicado: (2022)

Spatiotemporal scaling changes in gait in a progressive model of Parkinson's disease
por: Doyle, Alex M., et al.
Publicado: (2022)

Severe Constipation in Parkinson's Disease and in Parkinsonisms: Prevalence and Affecting Factors
por: Frazzitta, Giuseppe, et al.
Publicado: (2019)

Modern Brainstem MRI Techniques for the Diagnosis of Parkinson's Disease and Parkinsonisms
por: Arribarat, Germain, et al.
Publicado: (2020)

Editorial: Biomarkers of non-motor symptoms in Parkinson's disease and parkinsonisms
por: Filippi, Massimo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_541jv2va9pkqci0htt33e7pcu1